BGLC

Bionexus Gene La

• Reuters·03/31 21:26

  BioNexus Gene Lab expects delayed 2025 10-K filing after governance review

• Benzinga·03/31 12:05

  12 Industrials Stocks Moving In Tuesday's Pre-Market Session

• Benzinga·03/18 12:05

  12 Industrials Stocks Moving In Wednesday's Pre-Market Session

• Reuters·03/17 18:30

  BioNexus Gene Lab names Muthu Meyyappan chief commercial officer of Fidelion Diagnostics

• TipRanks·03/11 12:50

  Bionexus Gene Lab appoints Muthu Meyyappan as CCO, Fidelion

• Reuters·03/11 12:45

  BioNexus Gene Lab appoints Muthu Meyyappan as Fidelion Diagnostics chief commercial officer

• Dow Jones·03/11 12:45

  Press Release: BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard(TM) MRD Platform

• Benzinga·03/09 17:05

  12 Industrials Stocks Moving In Monday's Intraday Session

• Dow Jones·02/23 13:34

  *BioNexus Gene Lab: Chemrex's Bd Streamlined to Two Directors: Matthew L. Barsing, Chmn, and Angeline Chong >BGLC

• Dow Jones·02/23 13:32

  *BioNexus Gene Lab: Enhanced Bd Oversight Aligns Subsidiary With Disciplined Cap Allocation and Strategic Evaluation Framework >BGLC

• Dow Jones·02/23 13:32

  *BioNexus Gene Lab Appoints Matthew Barsing as Chairman >BGLC

• Reuters·02/23 13:30

  BioNexus Subsidiary Chemrex Names Matthew Barsing Chairman

• Reuters·02/23 13:30

  BIONEXUS GENE LAB CORP. COMPLETES CHEMREX GOVERNANCE RESTRUCTURING; APPOINTS MATTHEW BARSING AS CHAIRMAN

• Dow Jones·02/23 13:30

  Press Release: BioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as Chairman

• Reuters·02/03 21:11

  BioNexus Gene Lab Launches VitaGuard MRD Platform Across Southeast Asia